In rectal cancer specifically ... Tumor-Node-Metastasis (TNM) Staging System: A classification system used to describe the extent of cancer spread, based on the size of the tumor (T), the ...

Radiomics thus demonstrates considerable potential for optimizing clinical decision-making. In this paper, we reviewed recent research focusing on advances in the use of radiomics for managing rectal ...

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the ...

Cancer cases in India are rising, highlighting the importance of cancer registries for tracking, understanding, and treating ...

You’ve probably heard of “colorectal cancer,” but colon cancer and rectal cancer aren’t the same. If you or someone you’re close to has it, you’ll want to know what they have in common ...

Colorectal cancer can seem a lot like some common gastrointestinal (GI) disorders, including hemorrhoids, irritable bowel syndrome (IBS), an infection, or inflammatory bowel diseases (IBD), such ...

A new study found that the amount of calcium in a large glass of milk lowers a woman’s risk of developing colorectal cancer by 17% Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has ...

Consuming the amount of calcium found in a glass of milk could reduce the risk of colorectal cancer, according to a new study involving women. That was regardless of whether the calcium came from ...

There are many potential symptoms of colon cancer. Some are mild, and others may be more alarming. It’s important to speak with your doctor or healthcare professional if you have any of these ...

This classification allowed us to investigate the differences in microbiome composition and its association with treatment outcomes. The human colorectal cancer cell line HCT15 and HCT8 was purchased ...

Objective To determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs). Design The United ...

Safety and biomarker assessment of ST316, a novel peptide antagonist of ß-catenin, in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...